NFKB1 and inflammatory response: Furthermore, inhibition of PI3Kγ by CZC24832 significantly ameliorated CLP-induced cardiac inflammation and NF-κB activation, whereas the PI3Kα/δ/β inhibitor LY294002 had no significant effect (Figure 7).